Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Antitumor spectrum of Sch-66336 determined in human tumor cloning assay

July 14, 1999

Bristol-Myers Squibb patents new series of CDK inhibitors

July 14, 1999

Tetrionics will supply 2ME2 for EntreMed's preclinical testing program

July 14, 1999

Onconase/interferon combination exerts synergistic antitumor activity in vitro

July 14, 1999

NeXstar begins enrolling patients in U.S. phase I trial of NX-211

July 14, 1999

Selected purine analogues tested as angiogenesis inhibitors

July 14, 1999

Inhibitors of protein geranylgeranylation developed at Baldacci as antitumor agents

July 13, 1999

Indena presents novel paclitaxel derivatives with excellent antitumor activity

July 13, 1999

Structurally novel antitumor and immunosuppressive compounds from Klinge

July 13, 1999

Orphan Medical, Pierre Fabre sign letter of intent to license Busulfex

July 12, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...